ZOILA CONGLETON: Open Payments
NPI 1336152198 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 29 payments from 10 companies in 2025. Trend: 2023 $524 · 2024 $584 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $282 |
| Lilly USA, LLC | 5 | $123 |
| ABBVIE INC. | 3 | $70 |
| Amgen Inc. | 3 | $69 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Amphastar Pharmaceuticals, Inc. | 1 | $18 |
Products named: Ozempic, MOUNJARO, OTEZLA, Wegovy, INJECTAFER, UBRELVY, Rybelsus, QULIPTA.
Industry payments across VA — which companies pay providers there.
